Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.60
+0.34001.86%
Post-market: 18.600.00000.00%19:30 EDT
Volume:2.36M
Turnover:43.92M
Market Cap:59.20B
PE:-54.71
High:18.70
Open:18.56
Low:18.54
Close:18.26
52wk High:18.90
52wk Low:12.99
Shares:3.18B
Float Shares:3.09B
Volume Ratio:1.17
T/O Rate:0.08%
Dividend:0.65
Dividend Rate:3.47%
EPS(TTM):-0.3400
EPS(LYR):-0.3042
ROE:-2.26%
ROA:2.69%
PB:1.21
PE(LYR):-61.14

Loading ...

Takeda Pharmaceutical Company (TAK) Gets a Buy from Bank of America Securities

TIPRANKS
·
Yesterday

Takeda announces FDA acceptance of zasocitinib under priority review

TIPRANKS
·
Yesterday

Takeda's Investigational Plaque Psoriasis Drug Accepted for Priority Review by US FDA

MT Newswires Live
·
Yesterday

Market Chatter: Takeda, Other Biotech Firms to Announce New Drug Pricing Deals With White House

MT Newswires Live
·
Sep 01

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Aug 31

Takeda Pharmaceutical Says US FDA Approves Rusfertide for Rare Type of Blood Cancer

MT Newswires Live
·
Aug 31

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

Takeda's Mimrylo Gets FDA Approval to Treat Blood Cancer Condition

Dow Jones
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

Takeda announces Japan MHLW approval for Orzeyful

TIPRANKS
·
Aug 24

Takeda Secures Japan Approval for Orzeyful to Treat Narcolepsy Type 1

MT Newswires Live
·
Aug 24

Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Aug 18

Link Bilgisayar launches TÜBİTAK-backed smart city emission mapping project

TIPRANKS
·
Aug 12

Takeda award from Veterans Affairs posted to SAM.gov site

TIPRANKS
·
Aug 10

Takeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study

TIPRANKS
·
Aug 08

Analysts Conflicted on These Healthcare Names: Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinger (SDGR)

TIPRANKS
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Yomiuri: Japan Set to Approve Drug That Treats Narcolepsy

Dow Jones
·
Aug 06

Takeda Advances Pediatric Pouchitis Trial, Extending Entyvio’s Long‑Term Growth Story

TIPRANKS
·
Aug 04

Takeda Tracks Real World Safety of Ceprotin (TAK-662) in Rare Clotting Disorder

TIPRANKS
·
Aug 01